Navigation Links
Appel-Berci Cystic Duct Introducer Sets

ProductsAppel-Berci Cystic Duct Introducer Sets
Company Cook Surgical
Item Appel-Berci Cystic Duct Introducer Sets
Features 
  • Used for placement of choledochoscopes, cholangiography catheters and other instruments
  • Supplied sterile in peel-open packages
  • Intended for one-time use
  • Description Used for placement of choledochoscopes, cholangiography catheters and other instruments. Supplied sterile in peel-open packages. Intended for one-time use.
    Info Cook Surgical
    Customer Service: (800) 457-4500
    Web site: http://www.cookgroup.com

    Related medicine products :

    1. Tag-It Cystic Fibrosis PCR Mix
    2. Tag-It Cystic Fibrosis PCR Mix B
    3. Tag-It Cystic Fibrosis ASPE Mix B
    4. Tag-It Cystic Fibrosis ASPE Mix
    5. Tag-It™ Cystic Fibrosis Kit
    6. Culture, Cystic Respiratory
    7. Cystic Fibrosis 3199del6 Only(ARUP Medical Director or Genetic Counselor approval required prior to testing)
    8. Cystic Fibrosis, Atypical
    9. Cystic Fibrosis Cis-Trans
    10. Cystic Fibrosis, Mutation Panel, Fetal
    11. Cystic Fibrosis, MutationPanel
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products:
    (Date:2/27/2015)... Dr. Andrew Campbell, one of the ... to announce the expansion of Quintessa Aesthetic Center with ... has begun seeing patients on February 18, 2015. , ... offer a variety of state-of-the-art surgical and non-surgical ... laser peels, chemical peels, microdermabrasion, ProFractional Laser, Broad Band ...
    (Date:2/27/2015)... Daytona Beach, FL (PRWEB) February 27, 2015 ... marketing medical companies, devices and pharmaceuticals, Benedict Advertising ... FL as its newest client. The company’s patented ... is a pain-free, no-stress method of sedation. , ... taking medical patient comfort to a new level, ...
    (Date:2/27/2015)... (PRWEB) February 27, 2015 Victorian Hotel ... deals for couples who wanted to spend the auspicious ... opportunity to get a jump on Valentine’s Day with ... stay in one of their luxurious rooms. , ... 13, inviting guests for a mouthwatering 3 course meal ...
    (Date:2/27/2015)... February 27, 2015 The UC Davis ... expertise have made it a beacon of hope for ... has been acknowledged by the national society committed to ... Huntington’s Disease Society of America — as a Level ... acknowledgement recognizes the center’s service to over 300 families ...
    (Date:2/27/2015)... 27, 2015 “ Logical Operations ” ... Tech Report, which takes a look at the latest ... Mallory Sofastaii, a special reporter for NewsWatch and a ... how this company helps companies avoid cyber security threats. ... they’ll probably see cyber security somewhere in the headlines. ...
    Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 2Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 3Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2
    ... Ga., Feb. 24 As part of the ... search and recovery duties for fallen servicemen overseas, ... historical and practical importance of their mission from ... establishment of Biotrauma, Inc. - a death scene ...
    ... Inc. (TSX: NRI), a Canadian drug development company focused ... to and through the skin using its topical and ... platform, developed by its San Diego based research and ... of four finalists in the Science and Medical category ...
    ... Sheets: BEDA), a medical imaging and diagnostic Company launches new Physician ... out sourced billing services as part of its commitment to synergistically ... ... February 24, 2009 -- Bederra Corporation (Pink Sheets: BEDA), ...
    ... Protect Healthcare Workers from Hazardous Drug ExposureCOLUMBUS, Ohio, Feb. ... surrounding the safe handling of hazardous drugs in the ... National Safe Handling Awareness Month with Monday, April 20, ... Day. The proclamation of National Safe Handling Awareness ...
    ... leading IP Call -Management Software, Call-Shadow V5.0 will now support ... ... Hertfordshire, UK (PRWEB) February 24, 2009 -- Shadow Technology today ... V5.0 will now support the following new platforms:, , , ...
    ... rising costs of making funeral arrangements for your loved ones. It ... families to try to cut costs where ever possible. , ... West ... in New York, recently announced the launch of this new business to ...
    Cached Medicine News:Health News:USMC Crime Scene Cleaners Draw On Iraq Experience as Biotrauma, Inc. 2Health News:Nuvo's High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist 2Health News:Nuvo's High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist 3Health News:Bederra Corporation Launches New Billing Services Division Expected to Add up to $500,000 in Revenue 2Health News:Bederra Corporation Launches New Billing Services Division Expected to Add up to $500,000 in Revenue 3Health News:April 2009 Declared National Safe Handling Awareness Month 2Health News:April 2009 Declared National Safe Handling Awareness Month 3Health News:April 2009 Declared National Safe Handling Awareness Month 4Health News:Call-Shadow IP Call Management Software Now With Increased Platform Support 2Health News:Call-Shadow IP Call Management Software Now With Increased Platform Support 3Health News:Grief Counseling Services Battles Rising Costs of Funeral Expenses 2Health News:Grief Counseling Services Battles Rising Costs of Funeral Expenses 3
    (Date:2/27/2015)... , Feb. 27, 2015  Pomerantz LLP is ... Inc. ("Vitae" or the "Company") (NASDAQ: VTAE ... S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ... and certain of its officers and/or directors have violated ... of 1934.  On February 27, 2015, ...
    (Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... in the Proceedings of the National Academy ... when ibrutinib (IMBRUVICA ® ) was combined with ... tumor growth was enhanced suggesting a greater response ... and solid tumors with the combination. IMBRUVICA is ...
    (Date:2/27/2015)...  Acsis Inc., the market leader for supply chain ... John DiPalo , Acsis, Chief Strategy Officer, has ... Executive 2015 Provider Pro to Know. The award ... help prepare their companies, and customers, supply chains for ... list of Provider Pros to Know is featured in ...
    Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2